Hypha Labs (FUNI) Income from Continuing Operations (2010 - 2026)
Hypha Labs' (FUNI) quarterly Income from Continuing Operations came in at 521114.0 in Q1 2026, up 18.81% YoY from 438621.99 in Q1 2025, and little changed on a QoQ basis from 521638.0 in Q4 2025.
Hypha Labs (FUNI) Income from Continuing Operations (2010 - 2026) Analysis & Trends
Hypha Labs (FUNI) has 17 years of Income from Continuing Operations data on file, last reported at 521114.0 in Q1 2026.
- Quarterly Income from Continuing Operations rose 18.81% year-over-year to 521114.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 2163190.0 (down 13.89% YoY) and the FY2025 annual result came in at 3101901.0, down 61.68% from the prior year.
- Income from Continuing Operations steadied at 521114.0 in Q1 2026, from 521638.0 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 409174.0 in Q1 2024 to a low of 2373388.0 in Q3 2023.
- A 5-year average of 403743.53 and a median of 369018.0 in 2022 frame the typical range for Income from Continuing Operations.
- Annual changes were most pronounced in 2022 — Income from Continuing Operations sank 2378.83% — and 2023, when it surged 216.02%.
- Tracing FUNI's Income from Continuing Operations over 5 years: stood at 158690.0 in 2022, then advanced by 2.4% to 154877.0 in 2023, then tumbled by 764.97% to 1339641.0 in 2024, then surged by 61.06% to 521638.0 in 2025, then advanced by 0.1% to 521114.0 in 2026.
- The last three Income from Continuing Operations figures came in at 521114.0 (Q1 2026), 521638.0 (Q4 2025), and 558415.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 1.76 Bn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 870.00 Mn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | -66.93 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 339.00 Mn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 241.00 Mn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 338.41 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 207.00 Mn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 232.90 Mn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 299.10 Mn |
| 10 | Hypha Labs | 1.48 Mn | 1.47 Mn | - | -304,757.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -304,757.00 |
| Mar 31, 2026 | -521,114.00 |
| Dec 31, 2025 | -521,638.00 |
| Sep 30, 2025 | -558,415.00 |
| Jun 30, 2025 | -562,023.00 |
| Mar 31, 2025 | -641,822.00 |
| Dec 31, 2024 | -1.34 Mn |
| Mar 31, 2024 | 483,132.00 |
| Dec 31, 2023 | -154,877.00 |
| Sep 30, 2023 | 586,712.00 |
| Jun 30, 2023 | 402,569.00 |
| Mar 31, 2023 | 301,102.00 |
| Dec 31, 2022 | -158,690.00 |
| Sep 30, 2022 | -355,573.00 |
| Jun 30, 2022 | -218,063.00 |
| Mar 31, 2022 | -373,596.00 |
| Dec 31, 2021 | -277,603.00 |
| Sep 30, 2021 | -319,837.00 |
| Jun 30, 2021 | -177,214.00 |
| Mar 31, 2021 | 18,201.00 |